AGN

$ABBV AbbVie Has It All: Growth, Dividend Growth and Compelling Valuation (NYS:ABBV)

2019-06-25

Research Articles

Introduction I have held AbbVie (ABBV) since it was originally spun off from Abbott Labs.  Moreover, I have been aggressively adding to my position for clients needing current income and dividend growth.  All in all, it has been an excellent performer in spite of the fact that it is being ridiculously undervalued by Mr. Market.  […]

7 Intriguing Healthcare Growth Stocks in the S&P 500: Part 2

2016-08-11

Research Articles

Introduction The S&P 500 index is commonly used as a benchmark that investors use to measure the performance of their individual portfolios against.  However, the S&P 500 is comprised of a very diverse group of companies.  Just about every classification of company you can imagine can be found in the S&P 500.  Furthermore, it is […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.